For years, wellness enthusiasts and A-list celebrities like Jennifer Aniston and Prince Harry have been obsessed with monitoring their biometrics via Oura’s sleek smart rings. Now, a whole new group of people will be keeping a close eye on the company as it prepares to go public. The San Francisco-based firm revealed on Thursday that it has filed to list on the Nasdaq stock exchange in New York, potentially as early as this month. Investors are expecting a valuation significantly higher than the eleven billion dollars pegged during a funding round last year.
The financial health of the Finnish-born company looks just as robust as the vitals its devices track. In the nine months ending June 30, Oura reported revenue of 1.21 billion dollars, representing a seventy four percent jump year over year. More impressively, the business has officially crossed into profitability, posting sixty point eight million dollars in profit compared to just one point six million in the previous year. While hardware sales still drive eighty percent of its income, it is the recurring subscription model that is truly catching the eyes of Wall Street analysts.
With five million active subscribers and gross margins sitting at an enviable eighty nine percent, Oura has successfully turned health tracking into a steady stream of monthly income. Users pay between roughly six and seventy dollars a year for deep dives into their heart rate, sleep quality, and temperature data. This digital addiction is evident in the numbers; members open the app an average of three and a half times per day to check their stats.
Demographically, the brand has found massive success with younger audiences and women, who make up seventy two percent of its user base. By collecting nearly forty two billion hours of biometric data across fifty different metrics, Oura has positioned itself as a powerhouse in personal health analytics. As they launch newer iterations like the miniaturized Ring 5, the company moves from being a niche gadget maker to a major player in the global healthcare technology market.